Skip to Main Content
Outsourcing Facilities
Association
Apply
Outsourcing Facilities Association

The Voice ofAmerica’s503B OutsourcingFacilities

Federal and state advocacy, direct engagement with FDA, and a seat at the table for every FDA-registered outsourcing facility.

Congress created a third category in 2013. A 503B outsourcing facility compounds medicines in batches, under the same manufacturing-practice rules as a drug manufacturer, for the patients and providers no approved product reaches.

LegislationDrug Quality and Security Act2013

It is not a pharmacy filling one prescription at a time, and it is not a manufacturer selling an approved product.

The category exists because hospitals need medicines neither of those can supply: a unit dose ready to use at the bedside, a familiar drug without a common allergen, a product that has gone into shortage.

Read the OFA one-pager (PDF) (opens in a new tab)
A technician in a full cleanroom suit and hood works inside a laminar flow cabinet in a sterile suite.
Where a 503B sits: how a drug manufacturer, a 503B outsourcing facility and a compounding pharmacy compare.
Point of comparisonDrug manufacturer503B outsourcing facilitySection 503BCompounding pharmacySection 503A
Legal basisAn approved application — an NDA or an ANDASection 503B, added by the Drug Quality and Security ActSection 503A
Registers with FDAYes, as a drug establishmentYes, as an outsourcing facilityNo — licensed by the state board of pharmacy
Manufacturing standardCurrent good manufacturing practiceCurrent good manufacturing practiceUSP compounding chapters
Who inspectsFDAFDA, on a risk-based scheduleThe state board of pharmacy
PrescriptionAn approved product, dispensed on a prescriptionMay supply without a patient-specific prescriptionA patient-specific prescription is required
ScaleCommercial batchesBatches, supplied to hospitals and clinicsOne prescription at a time
Reports adverse events to FDARequiredRequiredNot required
Is the product FDA-approved?YesNoNo

Not a summary of positions. The record itself — comments, petitions, complaints and briefs, most of them published here as the document OFA filed.

16Documents since 2021

FDA

11 documents

Comments on guidance and policy, responses to citizen petitions, and nominations to the 503B bulk drug substances list.

  • February 13, 2025

    Petition

    Opposed Novo Nordisk’s citizen petition on OFA’s nomination of semaglutide to the 503B bulks list

    PDF (opens in a new tab)

  • November 15, 2024

    Comment

    Commented to FDA on the semaglutide shortage

    PDF (opens in a new tab)

  • October 31, 2024

    Comment

    Urged FDA to weigh stakeholder input to build a full understanding of outsourcing facilities

    PDF (opens in a new tab)

The courts

4 documents

Challenged FDA’s removal of semaglutide and tirzepatide from the drug shortage list, from the Northern District of Texas through the Fifth Circuit.

  • October 2025

    Amicus brief

    Filed an amicus brief at the U.S. Supreme Court

  • February 25, 2025

    Litigation

    Filed a reply brief in the challenge to FDA’s tirzepatide drug shortage resolution

    PDF (opens in a new tab)

  • February 24, 2025

    Litigation

    Sued FDA over the removal of semaglutide from the drug shortage list

    PDF (opens in a new tab)

Congress

1 document

Federal lobbying and an annual legislative day on Capitol Hill.

  • February 2026

    Endorsement

    Endorsed the Growing America’s Pharmaceutical Supply Act

Priorities

  • Quality
  • Transparency
  • Domestic Manufacturing
  • Patient Access
  • Mitigating Drug Shortages

OFA also works at state level — state lobbying and policy, tracked by its State Policy committee.

Filled glass ampoules move through a stainless steel rotary filling line.

Which outsourcing facility supplies the drug you cannot get?

A hospital that cannot obtain an FDA-approved drug should contact registered outsourcing facilities first: they compound in batches under a manufacturer’s standard. OFA keeps a public listing of what 503Bs supply, and 29 of the 34 drugs in it are on FDA’s shortage list.

Copied from OFA’s previous site on 4 November 2026, where the listing was last updated on 12 September.

  • Not every 503B listed is a member of OFA.
  • The information comes from the publicly available FDA website and the six-month product reports FDA publishes. 503Bs developing formulations that may be released soon may also be listed.
  • OFA makes no representation about the quantity or nature of any product listed. OFA has no pricing data. Please contact the 503B directly for a full product catalog.

Membership puts your facility inside the conversations, votes and meetings where the industry’s positions are set.

26calls a year

Member Conference Call, Every Other Week

Updates on federal and state lobbying, policy developments and OFA activities. All members may attend and raise the trends and issues affecting their facilities.

1vote per facility

Annual Board Meeting

Each facility member holds one board vote, giving every member a direct say in the association’s direction.

DCevery spring or summer

Legislative Day in Washington

Members are invited to join OFA on Capitol Hill to meet with lawmakers and make the case for outsourcing facilities in person.

5standing committees

Committee Participation

Members are welcome to serve on any OFA committee and help develop the association’s positions and work.

State PolicyCodingEducation / StandardsControlled SubstancesVeterinary

Membership is open to any FDA-registered outsourcing facility.

OFA is a voluntary membership organization. Every facility member holds one vote at the annual board meeting, whatever its size.

  1. Talk with us

    A call with Lee Rosebush or Sara Totri, to go through what membership involves for a facility your size. Dues are invoiced quarterly; they will go over them with you.

  2. Apply

    About five minutes. Have your facility’s FDA FEI number and a billing contact ready, or return the form by email to OFA@503bs.org.

  3. Get started

    Your first quarterly invoice, then the next member call, and whichever of the five committees you want a hand in.